{"filings":[{"id":1553156,"accession_number":"0001213900-26-076709","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-07-09T20:01:54+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC Holdings merges wholly owned subsidiary AGA Precision into A&B Aerospace","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["On July 2, 2026, AGA Precision Systems LLC merged into A&B Aerospace, Inc., with A&B as survivor.","All membership interests in AGA cancelled without consideration; A&B shares unaffected.","Merger effective July 2, 2026; internal reorganization of wholly owned subsidiaries.","No change in ownership or financial impact on PMGC Holdings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1501276,"accession_number":"0001213900-26-076053","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-07-07T21:18:15+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC sub NorthStrive Defense Tech gets exclusive license to U.S. Patent 12,291,334 for aerospace/defense","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["PMGC sub NorthStrive Defense Tech gets exclusive worldwide license to U.S. Patent 12,291,334 and know-how in aerospace/defense.","License includes sublicense rights; requires development plan, annual reports; milestone failure may be material breach.","Financial terms include license issue fee, annual maintenance fee, royalties, and sublicense payments; amounts redacted.","Term runs until last-to-expire royalty term; termination for breach or non-payment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1369957,"accession_number":"0001213900-26-073986","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-07-01T11:31:32+00:00","items":["7.01","9.01"],"status":"ready","headline":"NorthStrive Biosciences reports positive Phase III results: 4 AI-selected compounds increase ANT1 expression up to 50%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Four AI-selected compounds (C1, C2, C3, C4) significantly increased ANT1 expression in human skeletal muscle cells.","Strongest dose-dependent induction: C2 up to +50%, C4 up to +48%, C1 up to +46%, C3 +29% at highest dose.","Yuva Biosciences recommended advancing the four candidates into a more mature muscle model for confirmatory testing.","Results validate MitoNova AI platform's ability to identify biologically active small-molecule candidates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":920436,"accession_number":"0001213900-26-066351","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-06-08T21:08:45+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"PMGC Holdings shareholders approve staggered board with two classes, effective 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Proposal to classify Board into Class I (3-year terms) and Class II (1-year terms) passed with ~6.53M votes for (59.77% of outstanding).","All five nominated directors (Lichti, Bensler, Kovalyov, Daley, Parry) elected with ~99.8% of votes cast.","Ratification of HTL International as independent auditor for FY 2026 approved with 99.92% of votes cast.","Shareholders also approved potential adjournment of meeting, but company did not adjourn."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":887996,"accession_number":"0001213900-26-065791","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-06-05T20:01:25+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC subsidiary licenses FSU patent for defense tech; funds $490K research on UAV aquatic payload system","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exclusive worldwide license of US Patent 12,291,334 (multi-media parcel transport) from Florida State University Research Foundation for aerospace/defense field.","NorthStrive Defense Tech will fund $490,657 for 12-month research on UAV-dragged aquatic payload system at FSU's Center for Intelligent Systems, Control, and Robotics.","License includes tiered royalties, annual minimum royalty, annual maintenance fee, and sublicensing revenue share; specific amounts redacted.","Development plan covers 3–5 years; milestones and timelines are good-faith projections subject to change by mutual agreement.","NorthStrive receives a first option to negotiate a royalty-bearing license for any inventions arising from the research."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":49482,"accession_number":"0001213900-26-055405","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-05-13T10:05:52+00:00","items":["1.01","2.01","7.01","9.01"],"status":"ready","headline":"PMGC Holdings acquires A&B Aerospace for $4.5M cash; target posts $3.6M revenue, $344K net income in L9M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 100% of A&B Aerospace, a precision CNC machining contractor serving aerospace/defense.","Purchase price: $4.5M cash; $4.275M paid at closing, $225K held back for litigation indemnification.","Target revenue $3.607M for nine months ended Feb 2026 (vs. $3.197M prior); net income $343,903 (vs. loss of $108K).","Target had $681,509 cash, $1.447M net working capital, and a $225K accrued settlement liability at Feb 28, 2026.","President will continue leading Target under new employment agreement; Sellers subject to 3-year non-compete in CA."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96103,"accession_number":"0001213900-26-048252","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiary NorthStrive files U.S. patent for EL-22 muscle preservation in humans","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New U.S. patent application (No. 19/655,160) covers EL-22 as a formulated pharmaceutical product for muscle loss.","EL-22 uses myostatin-engineered probiotic technology targeting sarcopenia, disuse atrophy, and neurological disorders.","The patent includes dosing regimens and formulations; potential use with GLP-1 receptor agonist weight loss treatments.","This filing expands NorthStrive's IP strategy for muscle health therapeutics across pharmaceutical and adjacent markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96102,"accession_number":"0001213900-26-046876","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiary NorthStrive secures option for patented GPS-denied drone navigation tech","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Secured exclusive option to license U.S. Patent No. 12,277,716 B2 for GPS-denied autonomous drone navigation technology.","Technology uses visual-inertial odometry and cooperative swarm localization; addresses core DoD gap in GPS-jammed/spoofed environments.","Option covers aerospace/defense field; if exercised, parties will negotiate definitive licensing agreement for commercialization.","GPS-denied drone navigation market projected to grow at 31.7% CAGR through 2030 (Technavio).","NorthStrive will evaluate technology and engage potential strategic/government partners during option period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96101,"accession_number":"0001213900-26-045876","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SVM Machining (PMGC Holdings subsidiary) signs 5-year LTA with Turbo-Jet Products for aerospace/defense components","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SVM Machining signs Long-Term Agreement with Turbo-Jet Products Co. to supply mission-critical aerospace and defense components.","Agreement has initial five-year term with annual renewals; third long-term agreement signed by PMGC subsidiary in 2026.","SVM is ITAR-registered as of March 20, 2026, and actively pursuing AS9100 certification for regulated defense programs.","Agreement supports potential U.S. government and defense contracts under FAR and DFARS compliance.","PMGC Holdings (Nasdaq: ELAB) continues to grow its aerospace and defense supply chain presence in 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96100,"accession_number":"0001213900-26-044905","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-04-17T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"PMGC Holdings secures $40M equity purchase facility for M&A, initial $10M funded","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Initial tranche of ~$10 million funded at closing; facility provides up to $40M in pre-paid purchases over 24 months.","Proceeds to accelerate roll-up strategy in aerospace, defense, and industrial precision manufacturing; 4 acquisitions completed in past 12 months.","Terms include 7% OID on future draws, weekly sales cap of 15% of trading volume, and participation right up to 10% in subsequent financings.","Company agreed to reserve 7.5M shares for issuances; stockholder approval required under Nasdaq rules for shares exceeding 19.99%.","Guaranties from operating subsidiaries and pledge of equity interests secure the obligations under the facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96099,"accession_number":"0001213900-26-041738","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-04-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"AGA Precision Systems signs second long-term supply agreement with Tier 1 aerospace/defense firm","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Second LTA in 2026 with a globally recognized Tier 1 aerospace/defense company; first was with Turbo-Jet Products on March 31.","AGA will supply precision CNC-manufactured components for the customer's aerospace and defense programs.","Agreement includes defined performance commitments on quality, delivery, and pricing.","Customer identity not disclosed due to confidentiality obligations and ITAR requirements.","AGA believes LTA provides operational visibility and supports recurring revenue potential."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96098,"accession_number":"0001213900-26-041258","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-04-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC fully draws $20M equity facility from Streeterville Capital, details acquisitions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Utilized full $20M commitment from equity purchase facility with Streeterville Capital, LLC.","Acquired four companies in 2025-Q1 2026: Pacific Sun Packaging, AGA Precision, Indarg Engineering, SVM Machining.","Portfolio now spans aerospace, defense, semiconductor, medical device, and data center supply chains.","Near-term priorities include organic growth, selective M&A, and advancing Northstrive Biosciences' GLP-1 muscle preservation program.","Management believes acquisitions strengthen position in sectors with high switching costs and long-term retention."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96097,"accession_number":"0001213900-26-040150","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-04-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiary NorthStrive acquires exclusive option to license drone patent for air-water payload transport","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Option covers U.S. Patent No. 12,291,334 for a next-gen drone system operating across air and water.","Technology uses buoyancy-assisted transport to reduce energy consumption and improve payload efficiency.","Potential defense applications include littoral logistics, autonomous resupply, and sensor deployment.","Company will develop a commercialization plan and seek financing during the option period.","No guarantee of a definitive license agreement or successful commercialization."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96096,"accession_number":"0001213900-26-039335","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-04-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC forms defense tech subsidiary NorthStrive to target drone and autonomous systems","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Wholly owned subsidiary NorthStrive Defense Tech LLC established to focus on defense technology, drones, and autonomous systems.","Strategy includes acquiring, licensing, and partnering for advanced defense tech, leveraging existing subsidiaries AGA Precision and Silicon Valley Machining.","No assurance of successful commercialization or revenue; follow-up announcement planned.","PMGC believes defense sector growth is driven by global spending, regulatory shifts, and demand for unmanned systems."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109706,"accession_number":"0001213900-26-036840","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"AGA Precision Systems signs five-year supply deal with Turbo-Jet Products","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["AGA, wholly owned by PMGC Holdings (ELAB), entered a five-year LTA with Turbo-Jet Products to supply mission-critical aerospace/defense components.","The agreement includes annual renewal provisions and governs all future purchase orders under its term.","LTA supports U.S. government defense contracts and follows AGA's AS9100 certification and ITAR compliance.","No financial terms or revenue guidance were disclosed in the press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109705,"accession_number":"0001213900-26-035098","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC subsidiary Northstrive and MOA amend license milestones for BLS-M22, add amendment fee","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Third Amendment updates development milestones for human health field, including pre-clinical, IND, Phase 1-3, FDA marketing approval.","For BLS-M22, Phase 1 trial may be excused; milestone payment deferred to Phase 2 start.","PMGC to pay MOA a one-time amendment fee within 30 days of effective date (amount redacted).","Amendment effective as of March 24, 2026; signed by CEO Graydon Bensler and MOA COO Tiger Yoon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109704,"accession_number":"0001213900-26-033247","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-03-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiary SVM completes ITAR registration enabling defense contracts","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["SVM Machining secured ITAR registration from U.S. State Department's Directorate of Defense Trade Controls.","ITAR compliance allows SVM to pursue defense and aerospace programs requiring U.S. export-control standards.","Registration enhances SVM eligibility as qualified supplier to Tier 1 defense contractors and aerospace OEMs.","Milestone supports PMGC's targeted roll-up strategy in U.S.-based manufacturing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109703,"accession_number":"0001213900-26-032524","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-03-23T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC Holdings sets CEO annual fee at $300k, Chairman at $360k effective Jan 1, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO consultant fee (GB Capital Ltd, owned by Graydon Bensler) set at $300,000 per annum.","Chairman consultant fee (Northstrive Companies Inc., owned by Braeden Lichti) set at $360,000 per annum.","Fees apply for the 2026 fiscal year starting January 1, 2026, paid monthly in arrears.","No other changes to the existing consulting agreements with GB Capital and Northstrive."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109702,"accession_number":"0001213900-26-025681","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"PMGC Holdings to effect 1-for-6 reverse stock split on March 10, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 1:6 ratio, effective March 10, 2026 at 12:00 a.m. ET.","Post-split shares outstanding approximately 541,461; prior split 3,248,764.","CUSIP changed to 73017P508; trading symbol remains ELAB.","No fractional shares issued; holders receive one whole share for any fractional portion.","Outstanding warrants, options, and equity awards adjusted proportionally."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109701,"accession_number":"0001213900-26-022704","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC closes $8.1M secured pre-paid purchase; net proceeds $7.455M; OID $692,569","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Fourth Pre-Paid Purchase principal $8,147,569.50; OID $692,569.50; net purchase price $7,455,000.","Proceeds: $6.34M to new subsidiary's controlled deposit account, $651,806 to placement agent, $455,000 to company.","Investor converts at 88% of lowest 10-day VWAP; floor price $0.32; company prepayment at 120%.","Event of default triggers acceleration, 15% penalty, 18% interest; collateralized by deposit account and subsidiary equity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109700,"accession_number":"0001213900-26-018189","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-02-19T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiary files 10 US patent applications for EL-22/EL-32 in animal muscle growth","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["NorthStrive Biosciences, wholly owned by PMGC, filed ten US patent applications expanding EL-22 and EL-32 into animal health and agriculture.","Applications cover EL-22 (5 patents) and EL-32 (5 patents) for livestock, aquaculture, and poultry including muscle growth and yield.","Two applications target livestock muscle growth: EL-22 (19/541,209) and EL-32 (19/540,888).","Additional filings address emissions reduction in livestock and aquaculture, and poultry muscle development.","This expands PMGC's IP portfolio beyond human aesthetic medicine into animal agriculture markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109699,"accession_number":"0001213900-26-015003","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-02-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiary NorthStrive signs exclusive license for EL-22/EL-32 in animal health","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Definitive license with Modulant Biosciences for myostatin-engineered probiotic EL-22 and EL-32.","Modulant gets exclusive, royalty-bearing, sublicensable license for non-human animal health worldwide except Korea.","Modulant pays value (undisclosed) and handles development, manufacturing, regulatory, commercialization.","License excludes human pharmaceutical applications; shared ownership of improvements.","Follows binding term sheet from May 2025; no assurance of commercial success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109698,"accession_number":"0001213900-26-014285","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC subsidiary Northstrive grants exclusive animal-health license to Modulant Biosciences","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["License covers non-human animal health (feed additives) worldwide excluding South Korea.","Modulant pays revenue share; percentages and threshold amount are redacted.","License is subject to a head license; term ends on expiration of last valid patent claim.","Modulant agrees to non-compete for myostatin/Activin-A directed products during term.","Agreement incorporates binding term sheet dated May 12, 2025, previously disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109697,"accession_number":"0001213900-26-013263","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-02-06T23:59:59+00:00","items":["2.01","8.01","9.01"],"status":"ready","headline":"PMGC Holdings acquires SVM Machining for $2.45M cash plus earnouts up to $1.25M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Base purchase price $2.25M cash ($2M close, $250k holdback) plus $130k cash balance and $69k working capital adjustment.","SVM 2024 revenue $3.04M, net loss $194k; 2023 revenue $2.70M, net loss $679k.","Earnout: Tier 1 up to $750k if revenue $2.5M-$3.25M in 2026; Tier 2 up to $500k if $3.5M-$4.5M in 2027.","SVM is ISO 9001 certified CNC precision machiner serving medical, aerospace, biotech, semiconductor, and transportation.","This is PMGC's third California CNC acquisition, part of its multi-site machining platform strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109696,"accession_number":"0001213900-26-005641","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC Holdings enters $5M Secured Pre-Paid Purchase with Streeterville Capital","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Original principal $5,464,500; OID $464,500; net proceeds $4,562,840.","Investor can purchase shares at 88% of lowest VWAP over 10 trading days; floor price $1.05.","Company may prepay at 120% of outstanding balance; maturity 3 years from effective date.","Secured by equity interests in ELAB Holdings via pledge and security agreements.","9.99% ownership limitation on investor; events of default include bankruptcy, failure to deliver shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109695,"accession_number":"0001213900-26-003480","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC Holdings enters $3.28M secured pre-paid purchase with 88% discount conversion","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Original principal $3,278,700; OID $278,700; net proceeds $2,732,704 after fees.","Maturity Jan 7, 2029; company may prepay at 120% of outstanding balance.","Investor may convert at 88% of lowest 10-day VWAP; shares subject to 9.99% beneficial ownership cap.","Facility has extensive default provisions including 18% default interest and 15% balance increase."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109694,"accession_number":"0001213900-26-001782","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2026-01-06T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"PMGC Holdings effects 4-for-1 reverse stock split, shares outstanding drop to ~503,713","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split effective Jan 6, 2026 at 9:00 AM ET; every 4 shares combined into 1.","Pre-split shares outstanding ~2,014,852; post-split expected ~503,713.","No fractional shares issued; holders receive one full share for any fractional portion.","New CUSIP 73017P409; trading symbol 'ELAB' unchanged; options/warrants adjusted proportionally."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126214,"accession_number":"0001213900-25-124162","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-12-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiaries advance drug discovery program and achieve AS9100 certification","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["NorthStrive Biosciences advances to Phase III of AI drug discovery program with YuvaBio, targeting muscle preservation via mitochondrial function.","Phase III will generate biological data on AI-selected compounds, including cytotoxicity screening and ANT1 expression testing over 6-9 weeks.","AGA Precision Systems achieves AS9100 certification, the globally recognized quality standard for aerospace, defense, and space industries.","AGA is evaluating humanoid robotics integration for advanced manufacturing; no assurance of implementation or benefits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126213,"accession_number":"0001213900-25-120069","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-12-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"PMGC Holdings shareholders elect all five director nominees at 2025 Annual Meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All five director nominees elected with ~99.98% of votes cast (Braeden Lichti, Graydon Bensler, George Kovalyov, Juliana Daley, Jeffrey Parry).","Ratification of HTL International as independent auditor approved with 99.86% of votes (6,642,970 for).","Adjournment proposal approved (99.77% for); company states it will not adjourn the meeting.","93.46% of outstanding shares represented at the meeting; quorum was present."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126212,"accession_number":"0001213900-25-104070","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC Holdings subsidiary AGA Precision Systems obtains ITAR registration","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["AGA Precision Systems completed ITAR registration, complying with U.S. State Department export controls.","Registration enables AGA to pursue defense and aerospace programs requiring ITAR compliance.","Enhances eligibility as a qualified supplier to Tier 1 defense contractors and aerospace OEMs.","AGA operates CNC machining sites in Santa Ana and Hawthorne, CA for aerospace/defense components."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126211,"accession_number":"0001213900-25-104007","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["1.01","2.01","7.01","9.01"],"status":"ready","headline":"PMGC subsidiary AGA acquires Indarg Engineering assets for $548K; expands aerospace/defense CNC platform","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition price $548,000: $350K to satisfy SBA loan, $28K cash at closing, $170K two-year promissory note at 8% interest.","AGA hires Indarg's CEO Joel Alvarez as General Manager of Hawthorne site; employment agreement includes base salary, signing bonus, discretionary bonus, and incentive compensation.","Transaction closed Oct 26, 2025; Indarg's 40-year-old precision CNC machining business rebranded under AGA Precision Systems.","Seller agreed to 2-year non-compete and non-solicitation provisions; customary reps, warranties, and indemnities included."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126210,"accession_number":"0001213900-25-100797","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-10-21T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC Holdings amends secondment and consulting agreements with related parties GB Capital and Northstrive","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amends secondment pacts with GB Capital (CEO Graydon Bensler) and Northstrive (Chairman Braeden Lichti); fee set at 30% of employment costs.","Adds expense reimbursement for company cars, office space, mobile phones, and hiring costs for seconded staff.","Consulting agreements revised: clarifies non-employee, non-director status; renames 'severance' to 'termination payment' without changing obligations.","CEO consulting agreement adds $8,000 monthly housing reimbursement for Newport Beach services.","Board must approve any additions of seconded employees beyond those listed in new Exhibit A."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142958,"accession_number":"0001213900-25-092582","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PMGC Holdings secures up to $20M equity line; initial $5M pre-paid purchase closed with $3.99M net proceeds","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered into $20M equity line with institutional investor on Sept 23, 2025; initial $5M pre-paid purchase closed Sept 26 for net proceeds of $3.99M.","Conversion price set at 88% of lowest VWAP over prior 10 trading days; prepayment at 120% of outstanding balance; maturity Sept 26, 2028.","56,700 commitment shares and 10,300 pre-delivery shares issued; weekly sales capped at 15% of weekly dollar trading volume of ELAB.","Obligations secured by assets of subsidiaries AGA Precision Systems LLC and Pacific Sun Packaging Inc. via Guaranties, Security and Pledge Agreements.","Proceeds to be used for general corporate purposes, working capital, and potential acquisitions; Univest Securities received $400K cash fee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142957,"accession_number":"0001213900-25-088599","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-09-17T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"PMGC Holdings (ELAB) increases authorized shares to 2.5B (2B common, 500M preferred)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized common stock increased to 2,000,000,000 shares; preferred to 500,000,000, effective Sept 15, 2025.","CEO Graydon Bensler signed the Certificate of Amendment filed with Nevada Secretary of State.","Prior authorized share count not disclosed; the 5x increase enables future financings or acquisitions.","No changes to par value ($0.0001 per share) or any other charter/bylaw provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142956,"accession_number":"0001213900-25-084303","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-09-04T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"PMGC Holdings announces 3.5-for-1 reverse stock split effective Sept 2, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 3.5:1 ratio; effective September 2, 2025 at 9:30 am ET.","Post-split shares outstanding: approximately 677,000 (down from ~2.37 million pre-split).","Authorized common shares reduced from 285.7M to 81.6M; preferred shares unchanged at 500M.","Fractional shares eliminated; holders receive one full share for each fractional portion.","Outstanding warrants, stock awards, and options proportionally adjusted; CUSIP becomes 73017P300."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142955,"accession_number":"0001213900-25-080415","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-08-25T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"PMGC Holdings reduces warrant exercise price to $2.015, raises $1.67M, issues new warrants at $1.89","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $1,668,218.50 from exercise of Existing Warrants at reduced exercise price of $2.015 per share.","New unregistered warrants issued to purchase 827,900 shares of common stock at $1.89 per share.","Company to file registration statement for New Warrant Shares within 30 days and seek shareholder approval for issuance.","Univest Securities acted as exclusive warrant inducement agent, receiving 7% of gross proceeds ($146,775).","Existing warrants originally issued on January 27, 2025; exercise price reduced from $3.22 to $2.015."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142954,"accession_number":"0001213900-25-077686","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-08-18T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC Holdings amends Chairman & CEO consulting agreements to add acquisition-based awards of 5-8% of deal value","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amends consulting pacts for Chairman Lichti (Northstrive) and CEO Bensler (GB Capital) to add Acquisition Awards.","Awards range from 5% to 8% of total purchase price, with a discretionary 1% bonus if accretive or advancing strategic goals.","Awards can be taken as RSUs, restricted stock, or cash, fully vested upon closing of an acquisition.","Agreements renamed to 'Consulting and Services Agreement for Non-Employee, Non-Executive Chairman' and similar for CEO.","No acquisitions announced; this amendment solely adds M&A incentive compensation for top executives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142953,"accession_number":"0001213900-25-069744","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"PMGC terminates electronics LOI, targets CNC machine shops; pending aerospace acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Terminated non-binding LOI dated June 9, 2025 to acquire a U.S. electronics manufacturing company.","New M&A focus on CNC machine shops serving aerospace, defense, and industrial sectors.","Pending LOI for AS9100/ISO 9001-certified CNC precision machining company; 2024 revenue ~$4.5M, adjusted EBITDA ~$500K.","Secondment Agreement with CEO's wholly owned GB Capital to provide employees at agreed hourly rates.","U.S. metalworking machinery orders surged 32.6% MoM in March 2025 to $515.8M, cited as tailwind."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142952,"accession_number":"0001213900-25-066618","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["2.01","8.01","9.01"],"status":"ready","headline":"PMGC Holdings acquires AGA Precision Systems for $650K; adds ~$1.39M revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 100% of AGA Precision Systems LLC for $650,000 cash on July 18, 2025.","AGA generated over $1.39 million in revenue in 2024 with a track record of profitability.","Second bolt-on acquisition under PMGC's roll-up strategy; estimated total annualized revenue exceeds $2.25 million.","Seller agreed to 5-year non-competition and non-solicitation covenants.","AGA serves aerospace, defense, and industrial CNC machining and mold manufacturing markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142951,"accession_number":"0001213900-25-063334","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-07-11T23:59:59+00:00","items":["2.01","8.01","9.01"],"status":"ready","headline":"PMGC completes acquisition of Pacific Sun Packaging for $1.15M cash plus $250K earnout","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $1,148,000 cash plus up to $250,000 earnout contingent on $1,145,915 revenue in 2025 fiscal year.","Pacific Sun 2024 revenue $952,304 (down 21% YoY), net income $34,715; 2023 revenue $1,199,114, net income $7,512.","Target serves 300+ commercial clients; PMGC to continue operations from San Clemente lease with 5-year term.","Q1 2025 net loss $5,999 on revenue $108,850; total assets $404,167, liabilities $2,023 at March 31, 2025.","Acquisition marks launch of PMGC's strategic acquisition program targeting U.S. businesses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161039,"accession_number":"0001213900-25-056997","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-06-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC signs non-binding LOI to acquire CNC aerospace firm with $4.5M revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Target is a U.S.-based, AS9100/ISO 9001-certified CNC machining company founded in 1948.","2024 revenue of approx. $4.5M and adjusted EBITDA of $500K; serves Tier-1 aerospace clients.","Acquisition is subject to due diligence, corporate approvals, and execution of definitive documents.","PMGC (Nasdaq: ELAB) seeks to expand in certified domestic aerospace manufacturing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161038,"accession_number":"0001213900-25-055304","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-06-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC signs LOI to acquire profitable CNC shop; Northstrive advances obesity AI collaboration","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["LOI to acquire California CNC shop with $1.4M revenue, $215K adjusted EBITDA in 2024; AS9100D & ISO 9001:2015 certified.","Target has 35+ years history; third pending acquisition since April 2025, consistent with PMGC's M&A strategy.","Closing subject to due diligence, approvals, and definitive documentation; non-binding agreement.","Northstrive initiates Phase II with Yuva Biosciences using MitoNova AI to select small molecules for obesity and cardiac diseases.","Phase II aims to compile candidates for muscle preservation and metabolic health; builds on prior collaboration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161037,"accession_number":"0001213900-25-052531","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC signs LOI to acquire profitable electronics manufacturer; $699k revenue, $173k EBITDA","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Non-binding LOI to acquire a U.S. contract electronics maker with 40+ years history.","Target generated ~$699k revenue and ~$173k adjusted EBITDA in 2024.","This is PMGC's second pending acquisition since April 2025; more deals expected this year.","Acquisition aligns with reshoring tailwinds from the CHIPS Act and domestic manufacturing focus.","Closing subject to due diligence, approvals, and definitive documentation; no assurance given."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161036,"accession_number":"0001213900-25-044824","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"PMGC subsidiary Northstrive signs binding term sheet with Modulant for exclusive animal health license of EL-22","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Northstrive grants Modulant exclusive global rights (ex-Korea) to develop/commercialize EL-22 as a probiotic for livestock muscle preservation.","EL-22 targets the myostatin pathway via modified lactobacillus casei; Modulant is led by former Elanco executive Tom Campi.","Modulant will pay Northstrive a share of all sublicensing and commercial revenues, with a royalty rate that decreases after a dollar limit.","Definitive license agreement expected in coming months, subject to approval from Northstrive's head licensor for certain IP rights."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161035,"accession_number":"0001213900-25-042717","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC enters secondment agreement with Northstrive for employee services","summary_kind":"llm","event_type":"other","confidence":"medium","bullets":["Northstrive will second employees to PMGC; employees remain Northstrive staff, not PMGC employees.","PMGC reimburses Northstrive monthly at an agreed hourly rate times actual hours worked.","PMGC may terminate any employee secondment with 15 days' notice; either party may end the agreement with 90 days' notice.","Agreement includes standard confidentiality (5 years), indemnification, and $20K liability cap.","Exhibit A listing specific employees, hours, and rates was left blank in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161034,"accession_number":"0001213900-25-038049","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiary Northstrive files four new patent applications for EL-22 and EL-32 programs","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filing covers EL-22 in animals (App. 19/191,246) and EL-32 in obesity as monotherapy and with GLP-1 combos.","New patents also include EL-32 animal feed additive (App. 19/191,258) for muscle growth.","Northstrive's IP portfolio now totals 8 applications and 5 issued patents covering USA, Japan, Korea, China.","The filings aim to preserve muscle mass during obesity treatment and expand into animal health market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161033,"accession_number":"0001213900-25-034811","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC subsidiary Northstrive gets FDA support for IND submission of EL-22 with GLP-1 for obesity","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA agreed pharmacology studies support EL-22 activity and nonclinical studies appear adequate for safety/activity in overweight/obese humans.","Phase 1 and completed nonclinical data deemed adequate to allow initiation of a proposed Phase 2 clinical trial.","Northstrive aims to file IND in 2025 and start Phase 2 trial evaluating EL-22 combined with GLP-1 receptor agonists.","EL-22 is a patent-pending engineered probiotic designed to express myostatin, targeting muscle preservation during weight loss.","Preclinical data in mdx mice showed significant physiological and functional improvements; Phase 1 in South Korea showed good tolerability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161032,"accession_number":"0001213900-25-034788","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"PMGC Holdings enters $100M ATM equity facility with Univest; initial $1.74M registered","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered ATM Sales Agreement with Univest Securities to sell up to $100M of common stock.","Initial prospectus supplement filed for $1,737,635 of shares; sales made through Nasdaq or other markets.","Sales agent receives 3.5% commission on gross proceeds; agreement effective for 24 months from April 24, 2025.","Company may sell shares via Transaction Notices; no guarantee of any sales under the agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161031,"accession_number":"0001213900-25-032655","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-04-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"PMGC signs non-binding LOI to acquire profitable IT custom packaging company","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Target is a U.S.-based IT custom packaging firm founded in 2011, serving over 300 commercial clients including data centers.","Target has 90% U.S.-based revenue, positive EBITDA each year, and close to 15 years of uninterrupted operations.","PMGC expects to sign a definitive agreement and close the acquisition before end of Q2 2025.","Target's current operations team will remain; PMGC has initiated a financial audit of the target."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161030,"accession_number":"0001213900-25-030640","cik":1840563,"company_name":"PMGC Holdings Inc.","ticker":"ELAB","form_type":"8-K","filed_at":"2025-04-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"PMGC subsidiary Northstrive licenses Yuva Biosciences' AI platform for obesity and cardiometabolic drugs","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Northstrive (PMGC subsidiary, ticker ELAB) signs exclusive worldwide license for therapies in cardiac diseases and obesity.","YuvaBio to use its AI platform MitoNova to identify small molecule candidates targeting mitochondrial health.","Upfront fee, development milestone payments, and tiered royalties on net sales; no specific dollar amounts disclosed.","Multi-phase program includes in silico modeling, virtual screening, and wet-lab validation to shortlist candidates.","Agreement covers multi-year term; Northstrive may terminate for convenience with early termination fee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7769813.98265896,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2025-04-10T23:59:59+00:00|161030"}